US Stock MarketDetailed Quotes

WVE Wave Life Sciences

Watchlist

6.140
+0.260+4.42%

Close May 3 16:00 ET

6.140
0.0000.00%

Post 16:05 ET

751.04MMarket Cap-11370P/E (TTM)

Wave Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

84.79%-19.43M

0.60%-33.24M

-34.36%-34.46M

-29.27%-37.26M

314.49%85.52M

-43.59%-127.78M

-375.47%-33.44M

9.01%-25.65M

-206.58%-28.82M

10.15%-39.87M

Net income from continuing operations

64.46%-57.51M

62.81%-16.26M

118.59%7.25M

48.90%-21.1M

27.53%-27.41M

-32.38%-161.82M

-25.65%-43.71M

-526.07%-39M

-6.53%-41.3M

10.95%-37.81M

Operating gains losses

----

--12K

----

Depreciation and amortization

-8.98%9.21M

-12.55%2.18M

-12.96%2.26M

-7.27%2.32M

-3.02%2.44M

2.84%10.11M

-1.69%2.5M

8.51%2.6M

2.62%2.5M

2.20%2.51M

Change In working capital

183.86%19.08M

-543.19%-21.52M

-725.86%-46.26M

-791.52%-20.88M

1,360.99%107.74M

-4.11%6.72M

-77.41%4.86M

124.44%7.39M

-87.52%3.02M

-1.30%-8.54M

-Change in receivables

---21.09M

---14.09M

----

--0

----

-Change in prepaid assets

-46.88%-1.98M

-367.45%-2.4M

174.05%1.5M

-85.82%219K

-264.89%-1.3M

-135.01%-1.35M

-149.19%-513K

-229.60%-2.02M

24.32%1.54M

-9,000.00%-356K

-Change in payables and accrued expense

-137.25%-4.49M

-41.44%4.4M

-46.51%2.7M

-38.64%3.03M

-168.36%-14.6M

427.41%12.04M

129.92%7.51M

1,312.89%5.04M

423.70%4.93M

5.78%-5.44M

-Change in other current assets

-159.22%-2.01M

183.49%91K

-95.01%272K

48.04%-569K

-111.99%-1.8M

1,104.14%3.39M

92.13%-109K

20.50%5.45M

37.78%-1.1M

50.38%-851K

-Change in other current liabilities

-38.08%-5.69M

-95.83%-1.55M

-81.36%-1.68M

30.46%-1.45M

-222.19%-1M

5.57%-4.12M

63.55%-791K

-251.52%-928K

-113.06%-2.09M

67.16%-311K

-Change in other working capital

1,774.21%54.33M

-543.34%-7.97M

-27,742.38%-42.04M

-8,057.56%-22.11M

8,082.83%126.45M

82.43%-3.25M

29.80%-1.24M

98.92%-151K

---271K

---1.58M

Cash from discontinued investing activities

Operating cash flow

84.79%-19.43M

0.60%-33.24M

-34.36%-34.46M

-29.27%-37.26M

314.49%85.52M

-43.59%-127.78M

-375.47%-33.44M

9.01%-25.65M

-206.58%-28.82M

10.15%-39.87M

Investing cash flow

Cash flow from continuing investing activities

11.16%-1.12M

-101.43%-356K

60.48%-198K

-100.29%-72K

99.03%-489K

-124.11%-1.26M

165,700.00%24.84M

-411.22%-501K

7,360.77%24.61M

-46,388.89%-50.21M

Net PPE purchase and sale

11.16%-1.12M

-74.51%-356K

56.67%-198K

81.35%-72K

-135.10%-489K

-124.11%-1.26M

-1,260.00%-204K

-366.33%-457K

-13.86%-386K

-92.59%-208K

Net investment purchase and sale

--0

--25.04M

---44K

--25M

---50M

Cash from discontinued investing activities

Investing cash flow

11.16%-1.12M

-101.43%-356K

60.48%-198K

-100.29%-72K

99.03%-489K

-124.11%-1.26M

165,700.00%24.84M

-411.22%-501K

7,360.77%24.61M

-46,388.89%-50.21M

Financing cash flow

Cash flow from continuing financing activities

97.26%132.53M

170,740.00%93.96M

9,723.53%1.67M

-97.19%1.85M

2,563.60%35.05M

20.35%67.19M

-99.84%55K

-99.80%17K

1,204.26%65.8M

-84.77%1.32M

Net common stock issuance

150.89%131.28M

121,624.68%93.57M

888.02%1.32M

-96.57%1.76M

3,033.30%34.62M

-4.81%52.33M

-100.23%-77K

-102.08%-167K

920.10%51.46M

-86.37%1.11M

Proceeds from stock option exercised by employees

-91.54%1.26M

193.94%388K

92.39%354K

-99.41%85K

103.79%430K

1,632.28%14.86M

--132K

-42.86%184K

--14.34M

-60.63%211K

Cash from discontinued financing activities

Financing cash flow

97.26%132.53M

170,740.00%93.96M

9,723.53%1.67M

-97.19%1.85M

2,563.60%35.05M

20.35%67.19M

-99.84%55K

-99.80%17K

1,204.26%65.8M

-84.77%1.32M

Net cash flow

Beginning cash position

-40.24%92.16M

42.76%143.63M

39.29%176.64M

224.68%212.22M

-40.24%92.16M

-18.04%154.22M

-21.12%100.61M

-14.02%126.81M

-57.05%65.36M

-18.04%154.22M

Current changes in cash

281.07%111.99M

806.46%60.37M

-26.23%-32.99M

-157.60%-35.48M

235.29%120.09M

-83.39%-61.85M

-131.95%-8.55M

-31.09%-26.13M

1,411.86%61.59M

-147.66%-88.77M

Effect of exchange rate changes

54.76%-95K

-38.30%58K

57.89%-32K

29.58%-100K

75.58%-21K

-0.96%-210K

222.08%94K

-590.91%-76K

---142K

28.33%-86K

End cash Position

121.42%204.05M

42.76%143.63M

39.29%176.64M

224.68%212.22M

-40.24%92.16M

-21.12%100.61M

-14.02%126.81M

-57.05%65.36M

Free cash flow

84.09%-20.55M

0.15%-33.6M

-32.76%-34.66M

-27.34%-37.33M

312.15%85.03M

-44.21%-129.14M

-377.36%-33.64M

7.70%-26.1M

-200.97%-29.31M

9.90%-40.08M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	84.79%-19.43M	0.60%-33.24M	-34.36%-34.46M	-29.27%-37.26M	314.49%85.52M	-43.59%-127.78M	-375.47%-33.44M	9.01%-25.65M	-206.58%-28.82M	10.15%-39.87M
Net income from continuing operations	64.46%-57.51M	62.81%-16.26M	118.59%7.25M	48.90%-21.1M	27.53%-27.41M	-32.38%-161.82M	-25.65%-43.71M	-526.07%-39M	-6.53%-41.3M	10.95%-37.81M
Operating gains losses	----	----	----	----	----	--12K	----	----	----	----
Depreciation and amortization	-8.98%9.21M	-12.55%2.18M	-12.96%2.26M	-7.27%2.32M	-3.02%2.44M	2.84%10.11M	-1.69%2.5M	8.51%2.6M	2.62%2.5M	2.20%2.51M
Change In working capital	183.86%19.08M	-543.19%-21.52M	-725.86%-46.26M	-791.52%-20.88M	1,360.99%107.74M	-4.11%6.72M	-77.41%4.86M	124.44%7.39M	-87.52%3.02M	-1.30%-8.54M
-Change in receivables	---21.09M	---14.09M	----	----	----	--0	--0	----	----	----
-Change in prepaid assets	-46.88%-1.98M	-367.45%-2.4M	174.05%1.5M	-85.82%219K	-264.89%-1.3M	-135.01%-1.35M	-149.19%-513K	-229.60%-2.02M	24.32%1.54M	-9,000.00%-356K
-Change in payables and accrued expense	-137.25%-4.49M	-41.44%4.4M	-46.51%2.7M	-38.64%3.03M	-168.36%-14.6M	427.41%12.04M	129.92%7.51M	1,312.89%5.04M	423.70%4.93M	5.78%-5.44M
-Change in other current assets	-159.22%-2.01M	183.49%91K	-95.01%272K	48.04%-569K	-111.99%-1.8M	1,104.14%3.39M	92.13%-109K	20.50%5.45M	37.78%-1.1M	50.38%-851K
-Change in other current liabilities	-38.08%-5.69M	-95.83%-1.55M	-81.36%-1.68M	30.46%-1.45M	-222.19%-1M	5.57%-4.12M	63.55%-791K	-251.52%-928K	-113.06%-2.09M	67.16%-311K
-Change in other working capital	1,774.21%54.33M	-543.34%-7.97M	-27,742.38%-42.04M	-8,057.56%-22.11M	8,082.83%126.45M	82.43%-3.25M	29.80%-1.24M	98.92%-151K	---271K	---1.58M
Cash from discontinued investing activities
Operating cash flow	84.79%-19.43M	0.60%-33.24M	-34.36%-34.46M	-29.27%-37.26M	314.49%85.52M	-43.59%-127.78M	-375.47%-33.44M	9.01%-25.65M	-206.58%-28.82M	10.15%-39.87M
Investing cash flow
Cash flow from continuing investing activities	11.16%-1.12M	-101.43%-356K	60.48%-198K	-100.29%-72K	99.03%-489K	-124.11%-1.26M	165,700.00%24.84M	-411.22%-501K	7,360.77%24.61M	-46,388.89%-50.21M
Net PPE purchase and sale	11.16%-1.12M	-74.51%-356K	56.67%-198K	81.35%-72K	-135.10%-489K	-124.11%-1.26M	-1,260.00%-204K	-366.33%-457K	-13.86%-386K	-92.59%-208K
Net investment purchase and sale	--0	--0	--0	--0	--0	--0	--25.04M	---44K	--25M	---50M
Cash from discontinued investing activities
Investing cash flow	11.16%-1.12M	-101.43%-356K	60.48%-198K	-100.29%-72K	99.03%-489K	-124.11%-1.26M	165,700.00%24.84M	-411.22%-501K	7,360.77%24.61M	-46,388.89%-50.21M
Financing cash flow
Cash flow from continuing financing activities	97.26%132.53M	170,740.00%93.96M	9,723.53%1.67M	-97.19%1.85M	2,563.60%35.05M	20.35%67.19M	-99.84%55K	-99.80%17K	1,204.26%65.8M	-84.77%1.32M
Net common stock issuance	150.89%131.28M	121,624.68%93.57M	888.02%1.32M	-96.57%1.76M	3,033.30%34.62M	-4.81%52.33M	-100.23%-77K	-102.08%-167K	920.10%51.46M	-86.37%1.11M
Proceeds from stock option exercised by employees	-91.54%1.26M	193.94%388K	92.39%354K	-99.41%85K	103.79%430K	1,632.28%14.86M	--132K	-42.86%184K	--14.34M	-60.63%211K
Cash from discontinued financing activities
Financing cash flow	97.26%132.53M	170,740.00%93.96M	9,723.53%1.67M	-97.19%1.85M	2,563.60%35.05M	20.35%67.19M	-99.84%55K	-99.80%17K	1,204.26%65.8M	-84.77%1.32M
Net cash flow
Beginning cash position	-40.24%92.16M	42.76%143.63M	39.29%176.64M	224.68%212.22M	-40.24%92.16M	-18.04%154.22M	-21.12%100.61M	-14.02%126.81M	-57.05%65.36M	-18.04%154.22M
Current changes in cash	281.07%111.99M	806.46%60.37M	-26.23%-32.99M	-157.60%-35.48M	235.29%120.09M	-83.39%-61.85M	-131.95%-8.55M	-31.09%-26.13M	1,411.86%61.59M	-147.66%-88.77M
Effect of exchange rate changes	54.76%-95K	-38.30%58K	57.89%-32K	29.58%-100K	75.58%-21K	-0.96%-210K	222.08%94K	-590.91%-76K	---142K	28.33%-86K
End cash Position	121.42%204.05M	121.42%204.05M	42.76%143.63M	39.29%176.64M	224.68%212.22M	-40.24%92.16M	-40.24%92.16M	-21.12%100.61M	-14.02%126.81M	-57.05%65.36M
Free cash flow	84.09%-20.55M	0.15%-33.6M	-32.76%-34.66M	-27.34%-37.33M	312.15%85.03M	-44.21%-129.14M	-377.36%-33.64M	7.70%-26.1M	-200.97%-29.31M	9.90%-40.08M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall